As cases surge, the FDA has approved two new antibody treatments that have shown promise in high-risk patients. Experts worry about Thanksgiving turning into a super-spreader holiday.
President-elect Biden has reportedly choosen his secretary of state. President Trump has still not conceded the election. Plus, the U.S. recorded a million new COVID-19 cases in just six days.
NPR's Steve Inskeep talks to Dr. Elizabeth Hawes, a pediatrician at Commonwealth Pediatrics in Lexington, Ky., about the rise in the number of children testing positive for COVID-19.
Moncef Slaoui, the chief scientific adviser for Operation Warp Speed, says that some Americans could start receiving a COVID-19 vaccine by the second week of December.
NPR's Leila Fadel speaks with three doctors — Comilla Sasson, Ivan Melendez and Lynn Paxton — about what they're seeing on the frontlines of the latest surge in coronavirus cases.
As COVID-19 cases continue to soar across the country, officials are pleading with the public to rethink large holiday gatherings to mitigate the spread.
The experimental cocktail from the biotech company Regeneron is the same drug President Trump got when he was battling the coronavirus this year. It is designed for mild to moderate cases.
Europe is trying to battle a new COVID-19 spike with lockdowns. Although the short-term restrictions can be severe, people have free healthcare and income support from the region's governments.